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The Mesoamerican Ministers of Health have set 2020 as the target for malaria elimination to be achieved in the
region. Imported malaria cases are a potential threat to countries attempting elimination or working to prevent
resurgence. We report the first imported Plasmodium ovale infection with molecular confirmation in Central
America, which occurred in a Guatemalan soldier that had been deployed in Africa. The obstacles for its diagnosis
using the standard microscopy technique and the need to improve its detection are discussed.
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One factor in the worldwide increase of imported mal-
aria cases has been the presence of armed forces and
United Nations (UN) peacekeeping missions in malaria-
endemic areas and their subsequent return to their
countries of origin [1]. As expected, the majority of the
cases are caused by Plasmodium falciparum or P. vivax.
However, P.ovale infection has been established as a rele-
vant cause of imported malaria in these groups, resulting
in challenges for accurate diagnosis and treatment [2].
P. ovale is mainly distributed in sub-Saharian Africa
and the islands of western Pacific with prevalence be-
tween 3-10% depending on the region, population and
type of diagnostic tests used [3,4]. Recently, Sutherland
et al. demonstrated there are two non-recombining sym-
patric species of P. ovale, named P. ovale curtisi (classic
type) and P. ovale (variant type) [5]. In Latin America,
no autochthonous P. ovale cases have occurred and
there have been just a few reports of imported P. ovale
infections [6-8].* Correspondence: npadilla@ces.uvg.edu.gt
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unless otherwise stated.Guatemala is a Central American country, with ap-
proximately 80% of its territory considered a malaria
transmission setting [9]. P. vivax and P. falciparum are
the etiologic agents of malaria, with the last case of P.
malariae reported in 1971 and no P. ovale cases ever
documented in Guatemala [10]. In the last decade, and
largely based on the scale up of vector-control strategies,
a significant reduction in the number of malaria cases in
the country had been observed, from 39,703 cases in
2005 [11] to 3,292 cases in 2013 (Guatemalan Malaria
Control Program, unpublished data). The same trend
has been observed in all Mesoamerican countries and
the Española Islands (Dominican Republic and Haiti)
(Malaria Control Programs, unpublished data). Thus,
malaria programs in Guatemala and Mesoamerica are
now aiming towards malaria elimination rather than
only prevention and control. However, imported cases
pose a threat to this goal [12].
Since 2004, Guatemala has deployed military personnel
to contribute to UN peacekeeping missions. In 2010, an
epidemiological investigation detected 12 cases of
imported P. falciparum malaria in 150 Guatemalan sol-
diers returning from the Democratic Republic of the
Congo (DRC) [13,14]. Since this event, molecular screen-
ings to detect P. vivax /P. falciparum malaria carriers aretral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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the DRC as part of a program established between the
Guatemalan National Reference Laboratory, Universidad
del Valle de Guatemala and Military Healthcare and Social
Services. Here we present the first P. ovale case detected
in this population. To the best of our knowledge this is
the first report of molecularly-confirmed imported
P. ovale infection in Central America. The challenges that
this case presented for an accurate diagnosis and the need
to incorporate more sensitive methods will be discussed.
Case presentation
A 38-year-old male Guatemalan soldier presented to the
facilities of the Military Hospital on June 29, 2012, to
confirm suspected P. vivax malaria. Three months previ-
ously he had returned from a 9-month deployment in
Africa, as part of a Guatemalan Army operation to aid
the UN Organization Stabilization Mission in DRC.
The soldier reported that during his time in DRC he
stayed in the towns of Dungu, Bangadi and Bunia. He
travelled for a short period of time to Entebbe and
Kampala (Uganda) and Mombasa (Kenya) as part of his
rest and recuperation time. During the entire mission,
he used an untreated bed net and received mefloquine
prophylaxis (250 mg base/week). He reported high com-
pliance with the drug, although he admitted to skipping
some doses during his period in Uganda and Kenya.
Upon his return to Guatemala, he and all deployed
personnel were screened by malaria microscopy and
P.vivax/P.falciparum PCR. Microscopic and molecular
results were negative for the entire contingent.
Two months after his return to Guatemala, the patient
travelled to Puerto de San José, Escuintla (a coastal zoneFigure 1 Molecular detection of Plasmodium ovale in blood samples f
Plasmodium genus-conserved primers was followed by P. ovale specific prim
2.0% agarose gel stained with ethidium bromide and flanked by a 50 bp D
50 bp. Lane TBF: Patient’s thin blood film. LaneTBF-2: Patient’s thin blood fil
falciparum control. Lane Pv: Plasmodium vivax control. Lane Pm: Plasmodium
Negative control.in the southern Guatemala) and then returned to his
residence in Jalpatagua, Jutiapa (eastern region). Malaria
is endemic in both of these regions. He reported fatigue
and fever, and malaria was clinically diagnosed by a pri-
vate physician without any laboratory confirmation. He
was given chloroquine diphosphate injections (no avail-
able dosage data) because the standard treatment in
P. falciparum/P. vivax (the two endemic malaria para-
sites of the country) includes chloroquine [15].
The patient reported an improvement and returned to
military duties. Three weeks later, he again presented with
fever and fatigue. Malaria microscopy conducted at the
Jutiapa Malaria Vector Control Program erroneously diag-
nosed a P. vivax infection. The patient was transferred to
Guatemala City to be evaluated in the Military Medical
Center.
Venous and capillary blood was taken for laboratory test-
ing. A thin blood film identified P. vivax, although concerns
about the morphology of some of the observed parasites
were raised by the hospital microbiologist. A complete
blood count at admission revealed thrombocytopenia
(71,000 platelets/μl) and anemia (haemoglobin 12 g/dl). A
rapid dengue diagnostic assay showed a current or recent
infection. Other laboratory tests results were within refer-
ence values.
Based on the travel history of the patient and the
doubts arisen as to its species identity, molecular testing
was conducted to confirm the Plasmodium species. A
P. ovale mono-infection was identified on both the blood
film and whole blood of the patient using a Plasmodium
genus-specific nested PCR (Figure 1) and a SYBR Green-
based quantitative real-time PCR [16,17]. The blood film
was re-examined to identify the morphological features ofrom patient by the amplification of 18S gene. Nested PCR with
ers. PCR products were separated by electrophoresis through a
NA ladder (Novagen) as a size marker. Lane MM: Molecular marker
m (duplicate). Lane WB: Patient’s whole blood. Lane Pf: Plasmodium
malariae control. Lane Po: Plasmodium ovale positive control. Lane C-:
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to discriminate between the classic or variant P. ovale.
Basic local alignment search tool (BLAST) analysis re-
vealed 95% similarity with P. ovale ssrRNA gene. The
strain was classified as the classic type, P. ovale curtisi,
based on its nucleotide polymorphisms [5]. The Genetics
and Immunology Laboratory, Malaria Branch at Centers
for Disease Control (Atlanta, US) confirmed these findings.
For malaria treatment he was prescribed 1,500 mg of
chloroquine base given over 3 days and 15 mg of prima-
quine base over 14 days, following national guidelines
for the treatment of P. vivax infections, as the results of
the molecular analyses were not available at the time of
treatment initiation. The patient was discharged after his
clinical condition and hematological results improved.
Follow up specimens were taken at day 1, one and two
months after treatment completion, confirming parasite
clearance. Also, all family members in the household
and one neighbor provided blood samples, with negative
results for Plasmodium spp. As a control measure, the
household was sprayed with deltamethrin.
Here we present the first imported Plasmodium ovale
case in Guatemala. Based on the patient’s travel history, he
could have acquired the infection in any of the African
countries he stayed in, as P. ovale is present in all of them
[3,18]. Lack of strict compliance with both chemoprophy-
laxis and personal protective measures has been cited as a
cause of imported malaria in deployed military personnelFigure 2 Plasmodium ovale parasites (initially diagnosed as P. vivax) s
time of presentation (Giemsa Stain, X 1000). A and C: ring-form tropho[19]. The patient’s late onset of symptoms corresponds to
previous observations that anti-malarial prophylaxis de-
lays, but does not prevent, the primary attack [3].
This report highlights the need to consider P. ovale as a
cause of imported malaria and to include its detection, as
well as P. malariae, in imported malaria screening pro-
grams. This patient presented particular diagnostic chal-
lenges that resulted in a failure of early detection and
diagnosis of P. ovale infection. Distinguishing P. ovale from
P. vivax by microscopy, already difficult due to the species’
morphologic similarity [20], was further confounded in this
case by P. ovale’s non-indigenous status. Since this event,
all returning military contingents are being tested with a
pan-Plasmodium real time PCR assay. In addition to mal-
aria screening programs, clinical diagnoses should not
automatically exclude consideration of non-endemic spe-
cies of malaria. Regular training of microscopists for the
accurate identification of all malaria parasites, including
non-indigenous species, should be mandatory [21].
In addition to mitigating the diagnostic challenges of
imported malaria, monitoring imported cases into an
already malaria-endemic area is important because the
presence of viable vectors could lead to secondary autoch-
thonous cases and the spread of drug-resistant strains,
thus hampering malaria control and elimination efforts in
regions, such as Central America that remains one of the
few areas of the world where no antimalarial drug resist-
ance has been reported [22]. An observed change in thehown in different stages in the blood smear of the patient at
zoites. B and D: gametocytes.
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re-direct prevention efforts both internationally and
within Guatemala. Moreover, the combined use of mo-
lecular methods and microscopy will have the added bene-
fit of possibly increasing detection of asymptomatic
infections [23], allowing us to determine the true burden
of infection and potential interactions among Plasmodium
species [4].
Considering the long latency of these infections, fur-
ther strategies should be considered to improve preven-
tion. For instance, the use of presumptive anti-relapse
therapy could be an effective approach to prevent re-
lapses of P. vivax or P. ovale infections in long-term
Army deployments which are significantly exposed to
these parasites [24].Conclusions
Imported malaria cases could lead to the introduction of
drug resistant strains in Central America, as well as
atypical malaria species, especially in areas where com-
petent hosts could harbor these parasites and transmit
them [3]. An integrated and timely malaria surveillance
system is warranted in order to rapidly detect and con-
trol the emergence of these imported infections in the
country. In the era of malaria elimination, improved
guidelines for the diagnosis, treatment and control of
imported malaria cases are crucial in Mesoamerica to
mitigate the risk posed by such novel cases of imported
infections.Consent
Written informed consent was obtained from the patient
for publication of this Case Report. A copy of the writ-
ten consent is available for review by the Editor-in-Chief
of this journal.
Competing interests
The authors declared that they have no competing interests.
Authors’ contributions
All authors have made substantial contributions to the investigations
presented in this manuscript. MEC drafted the manuscript. SD, FE
participated in clinical and epidemiological data collection. MEC, EP, LP and
JLR carried out the laboratory and molecular studies. NP conceived and
designed the case report. All authors have read and approved the final
manuscript.
Acknowledgments
We want to thank the patient for his consent and enthusiastic participation
in this report. Also, many thanks to Kim Lindblade for revising the
manuscript and to Venkatachalam Udhayakumar and Naomi Lucchi for
confirming the molecular results. We also thank Ranfery Trampe for his
contribution in the epidemiological data collection in Jutiapa, Lucía Ortiz for
help in the bioinformatic analyses and Bernarda Molina for the microscopy
diagnosis and photography. Finally, we appreciate the diagnostic assistance
of the DPDx Team from the CDC’s Division of Parasitic Diseases and Malaria
for the identification of the blood stages of the parasite.Author details
1Center for Health Studies-Universidad del Valle de Guatemala (CES-UVG), 18
Av. 11-95 zona 15, Vista Hermosa III, Guatemala City, CA, Guatemala.
2National Reference Laboratory, Ministry of Health and Welfare, Km. 22,
Carretera al Pacífico, Barcenas, Villa Nueva, CA, Guatemala. 3F. Edward Hebert
School of Medicine, Uniformed Services, University of the Health Sciences,
4301 Jones Bridge Road, 20814 Bethesda, MD, USA. 4Global Disease
Detection Program, Centers for Disease Control and Prevention (CDC),
Central America Regional Office, 1600 Clifton Road NE, MS-D68, 30333
Atlanta, GA, USA. 5Military Healthcare and Social Services, Ministry of Defense,
Guatemala. Finca El Palomar, Acatan, Sta. Rosita Zona 16, Guatemala City,
Guatemala. 6Military Medical Center, Ministry of Defense, Guatemala. Finca El
Palomar, Acatan, Sta. Rosita Zona 16, Guatemala City, Guatemala.
Received: 15 July 2014 Accepted: 5 January 2015
References
1. World Health Organization. World malaria report 2011. Geneva: World
Health Organization; 2011.
2. de Laval F, Oliver M, Rapp C, Pommier de Santi V, Mendibil A, Deparis X,
et al. The challenge of diagnosing Plasmodium ovale malaria in travellers:
report of six clustered cases in French soldiers returning from West Africa.
Malar J. 2010;9:358.
3. Collins WE, Jeffery GM. Plasmodium ovale: parasite and disease. Clin
Microbiol Rev. 2005;18(3):570–81.
4. Mueller I, Zimmerman PA, Reeder JC. Plasmodium malariae and
Plasmodium ovale–the “bashful” malaria parasites. Trends Parasitol. 2007;23
(6):278–83.
5. Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C,
Pukrittayakamee S, et al. Two nonrecombining sympatric forms of the
human malaria parasite Plasmodium ovale occur globally. J Infect Dis.
2010;201(10):1544–50.
6. Meneses B, Blair S. Malaria por Plasmodium ovale. Acta Med Colomb.
1995;20(6):288–91.
7. Velázquez A, Álvarez F, Zavala C. Paludismo. Reporte de un caso y revisión
de la literatura. Med Sur. 2006;13(3):129–35.
8. Limongi JE, Costa DC, Carvalho LH, Lopes IS, Silva AA, Ferreira MS.
Plasmodium ovale malaria in Brazil: report of an imported case with a
prolonged incubation period. J Infect Dev Ctries. 2014;8(4):554–7.
9. Arevalo-Herrera M, Quiñones ML, Guerra C, Céspedes N, Giron S, Ahumada
M, et al. Malaria in selected non-Amazonian countries of Latin America. Acta
Trop. 2012;121(3):303–14.
10. Dirección General de Servicios de Salud. División de Malaria de Guatemala.
Memoria Anual 1977. Guatemala: Dirección General de Servicios de Salud.
División de Malaria de Guatemala; 1978.
11. World Health Organization. World malaria report 2013. Geneva: World
Health Organization; 2013.
12. Galappaththy GN, Fernando SD, Abeyasinghe RR. Imported malaria: a
possible threat to the elimination of malaria from Sri Lanka? Trop Med Int
Health. 2013;18(6):761–8.
13. Juliao PC, Sosa S, Gonzalez LD, Padilla N, Ortiz L, Goldman I, et al.
Importation of chloroquine-resistant Plasmodium falciparum by Guatemalan
peacekeepers returning from the Democratic Republic of the Congo. Malar
J. 2013;12(1):344.
14. Patel JC, Taylor SM, Juliao PC, Parobek CM, Janko M, Gonzalez LD, et al.
Genetic evidence of importation of drug-resistant plasmodium falciparum
to Guatemala from the democratic republic of the Congo. Emerg Infect Dis.
2014;20(6):932–40.
15. Ministerio de Salud Pública y Asistencia Social de Guatemala. Normas de
Atención en Salud Integral para el Primero y Segundo Nivel, 2010. Guatemala:
Ministerio de Salud Pública y Asistencia Social de Guatemala; 2010.
16. Mangold KA, Manson RU, Koay ES, Stephens L, Regner M, Thomson Jr RB,
et al. Real-time PCR for detection and identification of Plasmodium spp.
J Clin Microbiol. 2005;43(5):2435–40. doi:10.1128/jcm. 43.5.2435-2440.2005.
17. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, et al.
High sensitivity of detection of human malaria parasites by the use of
nested polymerase chain reaction. Mol Biochem Parasitol. 1993;61(2):315–20.
18. Oguike MC, Betson M, Burke M, Nolder D, Stothard JR, Kleinschmidt I, et al.
Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate
simultaneously in African communities. Int J Parasitol. 2011;41(6):677–83.
Castellanos et al. Military Medical Research  (2015) 2:3 Page 5 of 519. Shaha DP, Pacha LA, Garges EC, Scoville SL, Mancuso JD. Confirmed malaria
cases among Active Component U.S. Army Personnel, January-September
2012. MSMR. 2013;20(1):6–9.
20. Lim YA, Mahmud R, Chew CH, T T, Chua KH. Plasmodium ovale infection in
Malaysia: first imported case. Malar J. 2010;9:272.
21. Obare P, Ogutu B, Adams M, Odera JS, Lilley K, Dosoo D, et al.
Misclassification of Plasmodium infections by conventional microscopy and
the impact of remedial training on the proficiency of laboratory technicians
in species identification. Malar J. 2013;12:113.
22. World Health Organization. Global report on antimalarial drug efficacy and
drug resistance: 2000-2010. Geneva: World Health Organization; 2010.
23. Matisz CE, Naidu P, Shokoples SE, Grice D, Krinke V, Brown SZ, et al.
Post-arrival screening for malaria in asymptomatic refugees using real-time
PCR. Am J Trop Med Hyg. 2011;84(1):161–5.
24. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ. Primaquine: report
from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med
Hyg. 2006;75(3):402–15.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
